Invivyd (IVVD) director Terrance McGuire granted 50,000 stock options at $1.04

Rhea-AI Filing Summary

Invivyd, Inc. director Terrance McGuire received a grant of stock options covering 50,000 shares of common stock. The options have an exercise price of $1.04 per share and expire on May 18, 2036. All 50,000 options were reported as directly owned following this grant.

According to the award terms, the option vests in full on the earlier of May 19, 2027 or the date of Invivyd’s 2027 annual meeting of stockholders, as long as McGuire continues to serve the company through that vesting date. This is a compensation-related grant, not an open‑market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MCGUIRE TERRANCE

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	50,000	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 50,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 50,000 options Exercise price: $1.04 per share Expiration date: May 18, 2036 +2 more

5 metrics

Options granted 50,000 options Stock Option (Right to Buy) grant to director

Exercise price $1.04 per share Conversion or exercise price of stock options

Expiration date May 18, 2036 Option term for Invivyd stock options

Shares underlying options 50,000 shares Underlying Invivyd common stock

Vesting latest date May 19, 2027 Outside vesting date or earlier 2027 annual meeting

Key Terms

Stock Option (Right to Buy), Grant, award, or other acquisition, exercise price, Annual Meeting of Stockholders

4 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

exercise price financial

"conversion_or_exercise_price: "1.0400""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Annual Meeting of Stockholders financial

"the date of the Issuer's 2027 Annual Meeting of Stockholders"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCGUIRE TERRANCE

(Last) (First) (Middle)

C/O INVIVYD, INC.

209 CHURCH STREET

(Street)

NEW HAVEN CONNECTICUT 06510

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Invivyd, Inc. [ IVVD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.04	05/19/2026		A		50,000		(1)	05/18/2036	Common Stock	50,000	$0	50,000	D

Explanation of Responses:

1. This option was granted on May 19, 2026 and vests in full upon the earlier of (i) May 19, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.

	/s/ Jill Andersen attorney-in-fact for Terrance McGuire	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Invivyd (IVVD) director Terrance McGuire report?

Terrance McGuire reported receiving a grant of 50,000 stock options in Invivyd, Inc. The options give him the right to buy common shares at a fixed $1.04 exercise price, functioning as equity-based compensation rather than an open-market stock purchase.

What are the key terms of the new Invivyd (IVVD) stock options granted to Terrance McGuire?

The grant covers 50,000 stock options with a $1.04 per-share exercise price, expiring May 18, 2036. These options relate to Invivyd common stock and were reported as directly owned by McGuire following the transaction, according to the Form 4 disclosure.

When do Terrance McGuire’s Invivyd (IVVD) stock options vest?

The options vest in full on the earlier of May 19, 2027 or the date of Invivyd’s 2027 annual stockholders’ meeting. Vesting is conditioned on McGuire’s continuous service with the company through that applicable vesting date, as described in the Form 4 footnote.

Is Terrance McGuire’s Invivyd (IVVD) Form 4 transaction a stock purchase or sale?

The Form 4 reports a grant of stock options, not a market purchase or sale of shares. The transaction code “A” indicates a grant or award, giving McGuire the right to buy shares at $1.04 later, rather than immediately changing his common shareholdings.

How many Invivyd (IVVD) derivative securities does Terrance McGuire hold after this grant?

Following the reported transaction, McGuire holds 50,000 stock options tied to Invivyd common stock. The Form 4 shows these as the total derivative securities from this grant, with all 50,000 options directly owned after the award and no additional derivative positions listed.